drugset / Trial / NCT00002935

Photodynamic Therapy in Treating Patients With Early Esophageal Cancer

NCT00002935

Phase 2 Completed 30 enrolled Roswell Park Cancer Institute
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. This may be an effective treatment for esophageal cancer. PURPOSE: Phase II trial to study the effectiveness of photodynamic therapy in treating patients with Barrett's esophagus who have in situ esophageal cancer.

Timeline

Start
1995-10
Primary completion
2006-08
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule Intravenous

Indications